Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Coronary Artery Bypass Surgery With or Without Mitral Valve Annuloplasty in Moderate Functional Ischemic Mitral Regurgitation
2012
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: The second National Registry of Myocardial Infarction
2001
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction
2002
Comparative Effectiveness and Health Care Spending — Implications for Reform
2010
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
2003 Standout
Mechanisms of Thrombus Formation
2008 Standout
Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization
2004
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Temporal Trends in Cardiogenic Shock Complicating Acute Myocardial Infarction
1999
The Failing Heart — An Engine Out of Fuel
2007 Standout
Prospects for Cardiovascular Research
2001 StandoutNobel
Spinal-cord injury
2002 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Systematic Direct Angioplasty and Stent-Supported Direct Angioplasty Therapy for Cardiogenic Shock Complicating Acute Myocardial Infarction: In-Hospital and Long-Term Survival
1998
Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs
2007
Silver as Antibacterial Agent: Ion, Nanoparticle, and Metal
2012 Standout
Cardiac Support Devices
2009
Intravenous Low-Molecular-Weight Heparins Compared With Unfractionated Heparin in Percutaneous Coronary Intervention
2007
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
2019
Sex, Clinical Presentation, and Outcome in Patients with Acute Coronary Syndromes
1999
Silver nanoparticles tolerant bacteria from sewage environment
2011
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry
2000
Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia
1996
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty
2004
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Severe Sepsis and Septic Shock
2013 Standout
Acute myocardial infarction
2008
Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.
1997
Clinical Benefits of a Metabolic Approach with Trimetazidine in Revascularized Patients with Angina
2006
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry
2000
Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: Results of the STACK-on to ENOXaparin (STACKENOX) study
2009
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy
2016
Acute kidney injury
2019 Standout
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes
2007
Prevention of Heart Failure
2008
Sepsis and septic shock
2018 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Diabetes and Atherosclerosis
2002 Standout
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Diabetes and Mortality Following Acute Coronary Syndromes
2007
Polycystic Ovary Syndrome
2005 Standout
Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: Results from long-term follow-up of the Occluded Artery Trial (OAT) cohort
2012
Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention
2010
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
2003
Lack of Social Support in the Etiology and the Prognosis of Coronary Heart Disease: A Systematic Review and Meta-Analysis
2010
Myocardial Reperfusion Injury
2007 Standout
Bleeding after antithrombotic therapy in patients with acute ischemic heart disease
2007
Third Universal Definition of Myocardial Infarction
2012 Standout
Elective Intra-aortic Balloon Counterpulsation During High-Risk Percutaneous Coronary Intervention<subtitle>A Randomized Controlled Trial</subtitle>
2010
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
2000 Standout
Shock in acute myocardial infarction: the Cape Horn for trials?
2010
Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
2014 Standout
Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis
2013
The Percutaneous Ventricular Assist Device in Severe Refractory Cardiogenic Shock
2010
Cardiomyopathy induced by performance enhancing drugs in a competitive bodybuilder
2005
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine
2014 Standout
The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2
2001
Hemodynamic monitoring in shock and implications for management
2007
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Systems of Care
2008
Silver‐coated wool yarns with durable antibacterial properties
2012
Assessment of Clinical Criteria for Sepsis
2016 Standout
Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial
2008
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
In Situ Vibrational Spectroscopic Studies of the CaF2/H2O Interface
2001
Social isolation, loneliness, and all-cause mortality in older men and women
2013 Standout
Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes
2014
Abciximab Facilitates the Rate and Extent of Thrombolysis
1999
Air Pollution and Cardiovascular Disease
2004 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Acute Myocardial Infarction in Women
2016
Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction
2008
Green synthesis of metal nanoparticles using plants
2011 Standout
Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings
2009
Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
2003
Implications for complex cognition from the hafting of tools with compound adhesives in the Middle Stone Age, South Africa
2009 Standout
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase
2001
Living Alone and Cardiovascular Risk in Outpatients at Risk of or With Atherothrombosis
2012
Critical Analysis of Coronary Artery Bypass Graft Surgery: A 30-Year Journey
1998
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus
2015
Reversal of Cardiogenic Shock by Percutaneous Left Atrial-to-Femoral Arterial Bypass Assistance
2001
Sum-Frequency Vibrational Spectroscopy on Water Interfaces: Polar Orientation of Water Molecules at Interfaces
2006 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Clinical End Points in Coronary Stent Trials
2007 Standout
Metabolic Changes in Persons After Spinal Cord Injury
2000
Beyond Unfractionated Heparin and Warfarin
2007
Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
1995
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
2012 Standout
Explaining the Phenomenon of Nitrate Tolerance
2005
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
2008
Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease
2004
Evidence for Use of Coronary Stents: A Hierarchical Bayesian Meta-Analysis
2003
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Ten-Year Trends in the Incidence and Treatment of Cardiogenic Shock
2008
Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy
2019
Hydrophobic coagulation and aggregation of hematite particles with sodium dodecylsulfate
2006
Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study
1999
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Zygmunt Sadowski being referenced
Coronary Bypass Surgery with or without Surgical Ventricular Reconstruction
2009
Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction
2006
Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience
1995
The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome
1991
A randomized comparison of elective high-pressure stenting with balloon angioplasty: Six-month angiographic and two-year clinical follow-up
2000
Prophylactic lidocaine use in acute myocardial infarction: Incidence and outcomes from two international trials
1999
Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men
1996
The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone
2011
Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS‐II) trial
2010
[Comparative evaluation of the clinical effectiveness and the adverse effects of three different forms of nitrates in high oral doses in patients with stable angina pectoris].
2002
The role of surfactant salts on the spherical agglomeration of hematite suspension
2000
Evaluation of a Weight-Adjusted Single-Bolus Plasminogen Activator in Patients With Myocardial Infarction
1998
Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the Trimpol II study
2004
One-Year Results From the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) Trial
1996
Navigating the Crossroads of Coronary Artery Disease and Heart Failure
2006
Comparisons of Characteristics and Outcomes Among Women and Men with Acute Myocardial Infarction Treated with Thrombolytic Therapy
1997
Biological Synthesis of Gold Nanostructures Using the Extract of Trichoderma koningii
2009
Ice/Water Interface: Zeta Potential, Point of Zero Charge, and Hydrophobicity
1999
Long-Term Effects of Percutaneous Coronary Intervention of the Totally Occluded Infarct-Related Artery in the Subacute Phase After Myocardial Infarction
2011
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone
2002
Anti-Ischaemic Efficacy and Tolerability of Trimetazidine in Elderly Patients with Angina Pectoris
2000
Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
1998
Synthesis and antibacterial activity of of silver nanoparticles
2009